On Tuesday, September 11, 2012, Randy Mire, Owner of Gem Drugs in Reserve, LA will testify at the Subcommittee on Healthcare and Technology hearing in Washington, D.C. The hearing titled Medicare’s Durable Medical Equipment Competitive Bidding Program: How are Small Suppliers Faring?, will examine the bidding program to understand its impact on small suppliers.
The hearing will be held in Room 2360 of the Rayburn House Office Building at 10:00 A.M. Mire is a member of the Jefferson Chamber and the National Community Pharmacists Association.
For years, Medicare’s benefit for durable medical equipment, prosthetics, orthotics and supplies has been plagued by a fee schedule with high error rates and above-market costs for the Medicare program, beneficiaries and taxpayers. In response, in 2003, Congress established a competitive bidding program designed to provide greater value while ensuring beneficiary access to supplies and satisfaction with them.
According to the Centers for Medicare and Medicaid Services (CMS), in the first nine geographic areas, the program generated first year savings of about $202 million, or 42%, compared to costs expected under the fee schedule. The health care law expanded the competitive bidding program to additional areas and product categories. Many suppliers are small businesses, and CMS developed special considerations to assist small firms in winning contracts. Approximately 51% of winning suppliers are small suppliers (defined by gross revenue of $3.5 million or less), exceeding CMS’s goal of 30%. Still, some small businesses complain that the system favors large companies and they are at a competitive disadvantage.
For more information visit: http://smallbusiness.house.gov/calendar/eventsingle.aspx?EventID=307385#.UE4YRzMxXi4.email